NAL ER IPF Respiratory Function and Safety Study

Clinical trial NCT07036029 · COMPLETED

Trial details

NCT number: NCT07036029
Sponsor: Trevi Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2025-08-21
Primary completion: 2026-06-30
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.